Skip to content

Released Nov 3, 2026, after the close

10-Q filed Nov 3, 2026, 34 days after period end · 0001628280-26-069653

Q3 2026 · 10-Q
Revenue$352.65M+10.9% vs Q3 2025+3.7% vs Q2 2026
Net Income-$32.72MN/M vs Q3 2025N/M vs Q2 2026
EPS Diluted-$0.12N/M vs Q3 2025N/M vs Q2 2026
Gross Profit$170,477,000+6.2%
Operating Income$2,943,000−57.5%
Operating Cash Flowderived$21,099,000−55.8%
Free Cash Flowderived$4,032,000−87.2%
Margins · derived
Gross margin48.3%−2.2 pt vs Q3 2025
Operating margin0.8%−1.3 pt vs Q3 2025
Net margin-9.3%+8.7 pt vs Q3 2025

What the release said

Curaleaf Holdings, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2026, a copy of which is attached as Exhibit 99.1.

Curaleaf reported third quarter 2026 net revenue of $352.7 million, a 10.9% year-over-year increase from $317.9 million in Q3 2025.2

The company reported a net loss attributable to Curaleaf from continuing operations of $37.4 million, or $0.14 per share, and adjusted EBITDA of 77.6 million for the quarter.34

Curaleaf ended the quarter with total cash and cash equivalents of $104.9 million and repurchased 105,440 shares for a total of $1 million.56

Curaleaf commenced an Original Offer to purchase all outstanding common shares of Aurora Cannabis Inc. for SVS and cash, then enhanced the offer and increased the consideration.78

Q3 2026 net revenue
$352.7 million2
Q3 2026 net loss from continuing operations attributable to Curaleaf
$37.4 million3
Q3 2026 adjusted EBITDA
$77.6 million9
Nine months 2026 net revenue
$1,017.0 million10
Nine months 2026 net income from continuing operations attributable to Curaleaf
$45.2 million11
Thaler Agent · checked against the filing
Open the reading ›
The release

Same quarter

MetricQ3 2026Q3 2025
Revenue$352.65M$317.86M
Net Income-$32.72M-$57.03M
EPS Diluted-$0.12-$0.25

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Curaleaf Holdings, Inc. · CIK 1756770 · Engraved from SEC EDGAR